# Two enzyme structures vetted with Ramachandran plots before antidiabetic docking

Chemists used ProteinIQ's Ramachandran plot tool to vet two enzyme crystal structures before docking new metal complexes against diabetes targets.

[Matic Broz, PhD](https://proteiniq.io/authors/matic-broz)Nov 15, 20262 min

Paper[Synthesis, characterization, in vitro and in silico evaluation of furan-morpholine hybrid Schiff base metal(II) complexes for their potential antidiabetic and antioxidant activities](https://doi.org/10.1016/j.bioorg.2026.110733)

AuthorsSaira Nayab, Amjad Subhan, Haroon Ur Rashid, Sher Wali Khan, et al.

Published inBioorganic Chemistry · 2026-11 · Kyungpook National University

ProteinIQ in this studyBackbone dihedral angles of the α-glucosidase and α-amylase crystal structures were assessed with ProteinIQ's Ramachandran plot tool before docking.

Tools used[Ramachandran Plot](https://proteiniq.io/app/ramachandran-plot)

A docking score is only as good as the receptor behind it. A crystal structure with a strained backbone can give a number that reflects the error and not the chemistry, so Saira Nayab, Amjad Subhan, Haroon Ur Rashid, Hyosun Lee and colleagues checked their enzymes before docking anything.

The team had built a Schiff base ligand from a methylfuran and a morpholine group and bound it to cobalt, copper, zinc and cadmium. Type 2 diabetes involves both blood sugar and oxidative stress, so a compound that tackles both is attractive. They solved X-ray structures for the complexes, then measured DPPH radical scavenging and inhibition of two carbohydrate-digesting enzymes, α-glucosidase and α-amylase.

## Vetting the receptors

The docking targets came from the PDB: 3A4A for α-glucosidase and 1DHK for α-amylase. The ERRAT2 server checked non-bonded atom interactions for packing problems. The team then used the [Ramachandran plot](https://proteiniq.io/app/ramachandran-plot) tool on ProteinIQ to count residues in the favored, allowed and outlier regions of the φ/ψ map. Their methods say:

> In addition, the structures were also subjected to Ramachandran plot analysis using the web server ProteinIQ for assessing the stereochemical quality of the selected enzyme structures.

The reference list names the tool "Ramachandran Plot Generator Online" and gives an access date of 3 July 2026.

## One outlier in 683 residues

Both structures passed. For α-glucosidase (3A4A), 572 of 584 residues (97.95%) were in favored regions and the other 12 (2.05%) in allowed regions, with no outliers. ERRAT2 gave the same structure an overall quality factor of 93.772%.

For α-amylase (1DHK), 663 of 683 residues across chains A and B (97.07%) were favored and 19 (2.78%) allowed. One residue, Ser8 of chain A, was an outlier (0.15%).

## The complexes

The copper complex [Cu(MFM)Cl2] was the strongest antioxidant, with a DPPH IC50 of 3.01 μM, better than ascorbic acid. It also inhibited α-glucosidase with an IC50 of 5.22 μM, comparable to acarbose. The zinc complex [Zn(MFM)Cl2] was the best α-amylase inhibitor at 4.22 μM, which the authors report as clearly stronger than acarbose.

Docking scored -6.96 kcal/mol for copper with α-glucosidase and -7.24 kcal/mol for zinc with α-amylase. The authors call these preliminary and hypothesis-generating, because redocking confirmed the reference ligand poses but not the protocol for metal complexes. The assays carry the claim that zinc and copper furan-morpholine complexes are starting points for dual-action agents, and the structure checks show only that the enzyme models were sound to start from.

- Published November 15, 2026

## Written by

[Matic Broz, PhD](https://proteiniq.io/authors/matic-broz)Founder and computational chemist, ProteinIQ

Dr. Matic Broz is the founder of ProteinIQ and a computational chemist. He completed a PhD focused on protein structure, molecular dynamics, and neural networks, and writes about structural biology and scientific software.

- [LinkedIn](https://www.linkedin.com/in/maticbroz/)
- [Google Scholar](https://scholar.google.com/citations?user=KEYZJR4AAAAJ)
- [ORCID](https://orcid.org/0009-0008-4134-4631)

## Cite this article

Broz, M. (2026, November 15). Two enzyme structures vetted with Ramachandran plots before antidiabetic docking. ProteinIQ. https://proteiniq.io/customers/furan-morpholine-metal-complexes-ramachandran-plot

Sources1

1. 1[Synthesis, characterization, in vitro and in silico evaluation of furan-morpholine hybrid Schiff base metal(II) complexes for their potential antidiabetic and antioxidant activities](https://doi.org/10.1016/j.bioorg.2026.110733)Saira Nayab, Amjad Subhan, Haroon Ur Rashid, Sher Wali Khan, et al. · Bioorganic Chemistry · 2026

## More research evidence

[![First page of the Lacticaseibacillus paracasei bacteriocin genomics study by Romyasamit and colleagues, published in Antibiotics.](https://proteiniq.io/_next/image?url=%2Fimages%2Fcustomers%2Fpalm-sugar-bacteriocin-ramachandran-plot.webp&w=1920&q=75&dpl=dpl_7UnP1WeaWTToeLYR9CGTBoRfu8WH) Antimicrobial peptides · Oct 11, 2026 ### Good backbone, low confidence: Ramachandran checks on anti-MRSA bacteriocin models Researchers in Thailand used ProteinIQ's Ramachandran plot tool to check AlphaFold3 models of bacteriocin candidates from anti-MRSA palm sugar bacteria.](https://proteiniq.io/customers/palm-sugar-bacteriocin-ramachandran-plot)[![First page of the amnoonvirus segment 2 study by El Asely and colleagues, published in Microorganisms.](https://proteiniq.io/_next/image?url=%2Fimages%2Fcustomers%2Famnoonvirus-pb2-validation-molprobity.webp&w=1920&q=75&dpl=dpl_7UnP1WeaWTToeLYR9CGTBoRfu8WH) Structure validation · Apr 6, 2026 ### Real differences or modeling noise? Two tilapia virus variants, checked with MolProbity Michigan State researchers used MolProbity on ProteinIQ to confirm that predicted PB2 models of two Egyptian tilapia virus variants were sound before comparing them.](https://proteiniq.io/customers/amnoonvirus-pb2-validation-molprobity)[![First page of the recombinant BCG multi-epitope tuberculosis vaccine study by Zhang, Luo and colleagues, published in Frontiers in Cellular and Infection Microbiology.](https://proteiniq.io/_next/image?url=%2Fimages%2Fcustomers%2Ftuberculosis-multi-epitope-vaccine-alphafold-2.webp&w=1920&q=75&dpl=dpl_7UnP1WeaWTToeLYR9CGTBoRfu8WH) Vaccine design · Nov 14, 2026 ### A designed tuberculosis antigen with no crystal structure, modeled with AlphaFold 2 A Xinjiang team modeled a designed tuberculosis vaccine protein with AlphaFold2 on ProteinIQ before testing it in mice as recombinant BCG.](https://proteiniq.io/customers/tuberculosis-multi-epitope-vaccine-alphafold-2)

[All research](https://proteiniq.io/customers)

## Focus on research, not infrastructure

Start free with 200 credits a month and no installs. Upgrade when your project needs more compute.

[Start for free](https://proteiniq.io/sign-up)[View pricing](https://proteiniq.io/pricing)
